Bosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation study

por Isakoff, S J, Wang, D, Campone, M, Calles, A, Leip, E, Turnbull, K, Bardy-Bouxin, N, Duvillié, L, Calvo, E
Publicado 2014